Mereo BioPharma Group plc

General Information
Business:

(Note: Not an IPO: “Our ordinary shares trade on AIM, a market of the London Stock Exchange, under the symbol “MPH.” On April 4, 2018, the last reported sale price of our ordinary shares on AIM was £3.14 per ordinary share (equivalent to $17.62 per ADS based on an exchange rate of £1.00 to $1.4027).”

We are a multi-asset biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics that aim to improve outcomes for patients with rare and specialty diseases. Our portfolio consists of four clinical-stage product candidates, each of which we acquired from large pharmaceutical companies.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 37
Founded: 2015
Contact Information
Address Fourth Floor, One Cavendish Place, London W1G 0QF UK
Phone Number +44 (0) 33 3023 7300
Web Address http://www.mereobiopharma.com
View Prospectus: Mereo BioPharma Group plc
Financial Information
Market Cap $1515.3mil
Revenues $0 mil (last 12 months)
Net Income $-52.9 mil (last 12 months)
IPO Profile
Symbol MREO
Exchange NASDAQ
Shares (millions): 15.9
Price range $17.62 - $17.62
Est. $ Volume $280.0 mil
Manager / Joint Managers Cowen/ BMO Capital Markets/ RBC Capital Markets
CO-Managers JMP Securities/ Cantor Fitzgerald Europe
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change